Literature DB >> 17612791

Clinical and genetic analysis of HLXB9 gene in Korean patients with Currarino syndrome.

In-Suk Kim1, Soo-Young Oh2, Suk-Joo Choi2, Jong-Hwa Kim2, Kwan Hyun Park3, Hyun-Kyung Park4, Jong-Won Kim4, Chang-Seok Ki5.   

Abstract

Currarino syndrome (CS) is a rare autosomal dominant disease that has been described as a triad of partial sacral agenesis, anorectal anomalies, and a presacral mass. Mutations in the HLXB9 gene have been suggested to be the genetic background of CS. In this study, sequence analysis of the HLXB9 gene was performed in two familial and two sporadic Korean patients showing the clinical features of CS, and two mutations in the HLXB9 gene were identified only in the two familial cases. One mutation (R295W) has been reported previously, and the other (H260_Q261delinsLELLELE) is novel. Consistent with previous observations, the phenotypic expression of the mutation carriers in the CS families varies from mild to severe, including the complete triad. This study confirms that familial CS patients in Korea have the same genetic background as other ethnicities and reaffirms the phenotype variability among CS patients with the same mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612791     DOI: 10.1007/s10038-007-0173-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

1.  A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis.

Authors:  A J Ross; V Ruiz-Perez; Y Wang; D M Hagan; S Scherer; S A Lynch; S Lindsay; E Custard; E Belloni; D I Wilson; R Wadey; F Goodman; K H Orstavik; T Monclair; S Robson; W Reardon; J Burn; P Scambler; T Strachan
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

2.  The Currarino triad: the variable expression.

Authors:  Pieter J Emans; Gauke Kootstra; Carlo L M Marcelis; Emile A M Beuls; L W Ernest van Heurn
Journal:  J Pediatr Surg       Date:  2005-08       Impact factor: 2.545

3.  Population differences in the polyalanine domain and 6 new mutations in HLXB9 in patients with Currarino syndrome.

Authors:  Mercè Garcia-Barceló; Man-Ting So; Danny Ko-Chun Lau; Thomas Yuk-Yu Leon; Zheng-Wei Yuan; Wei-Song Cai; Vincent Chi-Hang Lui; Ming Fu; Jo-Anne Herbrick; Emily Gutter; Virginia Proud; Long Li; Jacqueline Pierre-Louis; Kirk Aleck; Ernest van Heurn; Elena Belloni; Stephen W Scherer; Paul Kwong-Hang Tam
Journal:  Clin Chem       Date:  2005-10-27       Impact factor: 8.327

4.  Hereditary sacral agenesis with presacral mass and anorectal stenosis: the Currarino triad.

Authors:  D S O'Riordain; P R O'Connell; W O Kirwan
Journal:  Br J Surg       Date:  1991-05       Impact factor: 6.939

5.  Triad of anorectal, sacral, and presacral anomalies.

Authors:  G Currarino; D Coln; T Votteler
Journal:  AJR Am J Roentgenol       Date:  1981-08       Impact factor: 3.959

6.  Spectrum of mutations and genotype-phenotype analysis in Currarino syndrome.

Authors:  J Köchling; M Karbasiyan; A Reis
Journal:  Eur J Hum Genet       Date:  2001-08       Impact factor: 4.246

Review 7.  Autosomal dominant sacral agenesis: Currarino syndrome.

Authors:  S A Lynch; Y Wang; T Strachan; J Burn; S Lindsay
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

8.  A previously unreported mutation in a Currarino syndrome kindred.

Authors:  Raymond Y Wang; Julie R Jones; Steve Chen; R Curtis Rogers; Michael J Friez; Charles E Schwartz; John M Graham
Journal:  Am J Med Genet A       Date:  2006-09-15       Impact factor: 2.802

9.  Currarino triad: anorectal malformation, sacral bony abnormality, and presacral mass--a review of 11 cases.

Authors:  S C Lee; Y S Chun; S E Jung; K W Park; W K Kim
Journal:  J Pediatr Surg       Date:  1997-01       Impact factor: 2.545

10.  Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene.

Authors:  D M Hagan; A J Ross; T Strachan; S A Lynch; V Ruiz-Perez; Y M Wang; P Scambler; E Custard; W Reardon; S Hassan; P Nixon; C Papapetrou; R M Winter; Y Edwards; K Morrison; M Barrow; M P Cordier-Alex; P Correia; P A Galvin-Parton; S Gaskill; K J Gaskin; S Garcia-Minaur; R Gereige; R Hayward; T Homfray
Journal:  Am J Hum Genet       Date:  2000-04-04       Impact factor: 11.025

View more
  7 in total

1.  Considering the Embryopathogenesis of VACTERL Association.

Authors:  R E Stevenson; A G W Hunter
Journal:  Mol Syndromol       Date:  2013-02

2.  Currarino syndrome: report of five consecutive patients.

Authors:  Soner Duru; Hakan Karabagli; Erhan Turkoglu; Yusuf Erşahin
Journal:  Childs Nerv Syst       Date:  2013-09-08       Impact factor: 1.475

3.  Kaposi sarcoma, oral malformations, mitral dysplasia, and scoliosis associated with 7q34-q36.3 heterozygous terminal deletion.

Authors:  Carolyn C Jackson; Alain Lefèvre-Utile; Anne Guimier; Valérie Malan; Julie Bruneau; Antoine Gessain; Olivier Cassar; Jeanne Amiel; Aurélie Cobat; Vimel Rattina; Laurent Abel; Jean-Laurent Casanova; Stéphane Blanche
Journal:  Am J Med Genet A       Date:  2017-05-09       Impact factor: 2.802

Review 4.  Associations of anorectal malformations and related syndromes.

Authors:  Sam W Moore
Journal:  Pediatr Surg Int       Date:  2013-04-09       Impact factor: 1.827

5.  Fatal Meningitis in a 14-Month-Old with Currarino Triad.

Authors:  Hanan Mohammed Al Qahtani; Khalid Suliman Aljoqiman; Hisham Arabi; Hesham Al Shaalan; Sumit Singh
Journal:  Case Rep Radiol       Date:  2016-08-11

6.  Spectrum of MNX1 Pathogenic Variants and Associated Clinical Features in Korean Patients with Currarino Syndrome.

Authors:  Seungjun Lee; Eun Jin Kim; Sung Im Cho; Hyunwoong Park; Soo Hyun Seo; Moon Woo Seong; Sung Sup Park; Sung Eun Jung; Seong Cheol Lee; Kwi Won Park; Hyun Young Kim
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

7.  Microcephaly, sensorineural deafness and Currarino triad with duplication-deletion of distal 7q.

Authors:  Piero Pavone; Martino Ruggieri; Ilaria Lombardo; Jyotsna Sudi; Roberta Biancheri; Danilo Castellano-Chiodo; Andrea Rossi; Gemma Incorpora; Norma J Nowak; Susan L Christian; Lorenzo Pavone; William B Dobyns
Journal:  Eur J Pediatr       Date:  2009-10-17       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.